Logo.jpg
ProPhase Labs Acquires Digital Covid Vaccination and Testing “Passport” Solution
30 mars 2021 17h10 HE | ProPhase Labs, Inc.
 New Reporting App Simplifies Documentation of User Vaccination and Covid Testing Statue – Easily Enables Clear Access to Air/Rail/Bus Travel, Concert & Sporting Events GARDEN CITY, NY, March...
Logo.jpg
ProPhase Labs to Host Fourth Quarter and Full Year 2020 Financial Results Conference Call on Wednesday, March 31, 2021 at 4:30 p.m. Eastern Time
15 mars 2021 08h30 HE | ProPhase Labs, Inc.
GARDEN CITY, NY, March 15, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified medical science and technology company, will hold a conference call on Wednesday, March 31, 2021...
Logo.jpg
ProPhase Labs Begins Advanced, Saliva-based Viral PCR Multiplex-Testing for COVID-19, Influenza A & B, and Other Viruses After FDA Confirmation of Two Emergency Use Authorizations
09 févr. 2021 08h30 HE | ProPhase Labs, Inc.
Company Integrates Spectrum Solutions™ SDNA-1000 Saliva Collection System for Advanced, Simultaneous Multi-Viral Detection of Infections and Viral Mutations GARDEN CITY, NY, Feb. 09, 2021 ...
Logo.jpg
ProPhase Labs Exceeding Initial Goals as Covid-19 Lab Testing Business Ramps up
01 févr. 2021 08h30 HE | ProPhase Labs, Inc.
Company to Host Business Update Shareholder’s Conference Call on February 10, 2021 at 11:00 a.m. Eastern Time GARDEN CITY, NY, Feb. 01, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ:...
Logo.jpg
ProPhase Labs Announces Opening of Large CLIA Lab Covid Testing Facility in Garden City, New York
29 janv. 2021 08h30 HE | ProPhase Labs, Inc.
- Total Company Processing Capacity On Track to Reach 60,000 Tests Per Day – GARDEN CITY, NY, Jan. 29, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified medical...
Logo.jpg
ProPhase Labs, Inc. Announces Closing of Public Offering
21 janv. 2021 16h30 HE | ProPhase Labs, Inc.
Garden City, NY, Jan. 21, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified medical science and technology company, today announced the closing of its previously announced...
Logo.jpg
ProPhase Labs Announces Pricing of Public Offering of Common Stock
18 janv. 2021 21h50 HE | ProPhase Labs, Inc.
GARDEN CITY, NY, Jan. 18, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified medical science and technology company, announced today the pricing of an underwritten public...
Logo.jpg
ProPhase Labs Announces Proposed Public Offering of Common Stock
15 janv. 2021 17h21 HE | ProPhase Labs, Inc.
GARDEN CITY, NY, Jan. 15, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified medical science and technology company, announced today that it has commenced a proposed...
Logo.jpg
ProPhase Labs to Present at the NobleCon17 Annual Small & Microcap Investor Conference on Tuesday, January 19, 2021 at 12:45 p.m. Eastern Time
11 janv. 2021 08h30 HE | ProPhase Labs, Inc.
Company Exceeding Near Term Goals & Expands 2021 Testing Capacity Surpasses Targeted $30 Net Profit Margin Per COVID-19 Test GARDEN CITY, NY, Jan. 11, 2021 (GLOBE NEWSWIRE) -- ProPhase...
Logo.jpg
ProPhase Labs Announces $5.5 Million Registered Direct Offering of Common Stock and Warrants
05 janv. 2021 12h10 HE | ProPhase Labs, Inc.
GARDEN CITY, NY, Jan. 05, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified medical science and technology company, today announced that it has entered into a definitive...